The risk of CNS involvement in aggressive lymphomas in the rituximab era. [electronic resource]
Producer: 20140609Description: 643-52 p. digitalISSN:- 1747-4094
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Central Nervous System Neoplasms -- complications
- Humans
- Lymphoma, Non-Hodgkin -- complications
- Methotrexate -- administration & dosage
- Recurrence
- Risk Factors
- Rituximab
- Stem Cell Transplantation
- Transplantation, Autologous
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.